Drugs / Opioid Growth Factor (OGF)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00783172 | Jan 2009 → Aug 2010 | malignant pancreatic neoplasm | Milton S. Hershey Medical Center | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Opioid Growth Factor (OGF) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00783172 ↗ |
| Route | Intravenous | “Initial treatment is 150ug/kg (based on body weight of the patient) in a volume of 50ml sterile saline, IV (in the vein) over 45 minutes” NCT00783172 ↗ |